Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation

Journal of Virology

Volumn 80, Issue 21, 2006, Pages 10487-10496

  Granja, Aitor G ^a   Sabina, Prado ^a   Salas, María L ^a   Fresno, Manuel ^a   Revilla, Yolanda ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HISTONE ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEIN A238L; PROTEIN P300; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACETYLATION; AFRICAN SWINE FEVER VIRUS; ANIMAL CELL; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS INFECTION;

ACETYLATION; AFRICAN SWINE FEVER VIRUS; ANIMALS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; DNA, VIRAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); SWINE; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

AFRICAN SWINE FEVER VIRUS;

EID: 33750309635     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00862-06     Document Type: Article

References (42)

1. Ait-Si-Ali, S., S. Ramirez, F. X. Barre, F. Dkhissi, L. Magnaghi-Jaulin, J. A. Girault, P. Robin, M. Knibiehler, L. L. Pritchard, B. Ducommun, D. Trouche, and A. Harel-Bellan. 1998. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396:184-186.
2. Bannister, A. J., and E. A. Miska. 2000. Regulation of gene expression by transcription factor acetylation. Cell. Mol. Life Sci. 57:1184-1192.
3. Berger, S. L. 1999. Gene activation by histone and factor acetyltransferases. Curr. Opin. Cell Biol. 11:336-341.
4. Boyes, J., P. Byfield, Y. Nakatani, and V. Ogryzko. 1998. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396:594-598.
5. Bustos, M. J., M. L. Nogal, Y. Revilla, and A. L. Carrascosa. 2002. Plaque assay for African swine fever virus on swine macrophages. Arch. Virol. 147:1453-1459.
6. Carrascosa, A. L., J. F. Santaren, and E. Vinuela. 1982. Production and titration of African swine fever virus in porcine alveolar macrophages. J. Virol. Methods 3:303-310.
7. Chen, H., M. Tini, and R. M. Evans. 2001. HATs on and beyond chromatin. Curr. Opin. Cell Biol. 13:218-224.
8. Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21:6539-6548.
9. Chu, S. C., J. Marks-Konczalik, H. P. Wu, T. C. Banks, and J. Moss. 1998. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun. 248:871-878.
10. Croen, K. D. 1993. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Investig. 91:2446-2452.
11. Deng, W. G., and K. K. Wu. 2003. Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. J. Immunol. 171:6581-6588.
12. Deng, W. G., Y. Zhu, and K. K. Wu. 2003. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J. Biol. Chem. 278:4770-4777.
13. Dixon, L. K., C. C. Abrams, G. Bowick, L. C. Goatley, P. C. Kay-Jackson, D. Chapman, E. Liverani, R. Nix, R. Silk, and F. Zhang. 2004. African swine fever virus proteins involved in evading host defence systems. Vet. Immunol. Immunopathol. 100:117-134.
14. Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
15. Falvo, J. V., A. M. Uglialoro, B. M. Brinkman, M. Merika, B. S. Parekh, E. Y. Tsai, H. C. King, A. D. Morielli, E. G. Peralta, T. Maniatis, D. Thanos, and A. E. Goldfeld. 2000. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol. Cell. Biol. 20:2239-2247.
16. Furia, B., L. Deng, K. Wu, S. Baylor, K. Kehn, H. Li, R. Donnelly, T. Coleman, and F. Kashanchi. 2002. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. J. Biol. Chem. 277:4973-4980.
17. Giles, R. H., D. J. Peters, and M. H. Breuning. 1998. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14:178-183.
18. Granja, A. G., M. L. Nogal, C. Hurtado, C. Del Aguila, A. L. Carrascosa, M. L. Salas, M. Fresno, and Y. Revilla. 2006. The viral protein A238L inhibits TNF-{alpha} expression through a CBP/p300 transcriptional coactivators pathway. J. Immunol. 176:451-462.
19. Granja, A. G., M. L. Nogal, C. Hurtado, V. Vila, A. L. Carrascosa, M. L. Salas, M. Fresno, and Y. Revilla. 2004. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. J. Biol. Chem. 279:53736-53746.
20. Griffith, O. W., and D. J. Stuehr. 1995. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 57:707-736.
21. Janknecht, R., and T. Hunter. 1996. Transcription. A growing coactivator network. Nature 383:22-23.
22. Jun, C. D., C. D. Oh, H. J. Kwak, H. O. Pae, J. C. Yoo, B. M. Choi, J. S. Chun, R. K. Park, and H. T. Chung. 1999. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. J. Immunol. 162:3395-3401.
23. Karupiah, G., Q. W. Xie, R. M. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-1448.
24. Lin, A. W., C. C. Chang, and C. C. McCormick, 1996. Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5′-flanking region. J. Biol. Chem. 271:11911-11919.
25. Lowenstein, C. J., E. W. Alley, P. Raval, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730-9734.
26. Martin, A. G., and M. Fresno. 2000. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J. Biol. Chem. 275:24383-24391.
27. Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157.
28. Miskin, J. E., C. C. Abrams, L. C. Goatley, and L. K. Dixon. 1998. A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science 281:562-565.
29. Nakamichi, K., S. Inoue, T. Takasaki, K. Morimoto, and I. Kurane. 2004. Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. J. Virol. 78:9376-9388.
30. Nathan, C. F., and J. B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
31. Neilan, J. G., Z. Lu, G. F. Kutisb, L. Zsak, T. L. Lewis, and D. L. Rock. 1997. A conserved African swine fever virus IkappaB homolog, 5EL, is nonessential for growth in vitro and virulence in domestic swine. Virology 235:377-385.
32. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
33. Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523-527.
34. Revilla, Y., M. Callejo, J. M. Rodriguez, E. Culebras, M. L. Nogal, M. L. Salas, E. Vinuela, and M. Fresno. 1998. Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein. J. Biol. Chem. 273:5405-5411.
35. Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10: 3805-3817.
36. Snowden, A. W., L. A. Anderson, G. A. Webster, and N. D. Perkins. 2000. A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation. Mol. Cell. Biol. 20:2676-2686.
37. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100.
38. Wang, T., M. Ward, P. Grabowski, and C. J. Secombes. 2001. Molecular cloning, gene organization and expression of rainbow trout (Oncorhynchus mykiss) inducible nitric oxide synthase (iNOS) gene. Biochem. J. 358:747-755.
39. Xie, Q. W., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
40. Yuan, L. W., and J. E. Gambee. 2000. Phosphorylation of p300 at serine 89 by protein kinase C. J. Biol. Chem. 275:40946-40951.
41. Zhang, H., X. Chen, X. Teng, C. Snead, and J. D. Catravas. 1998. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem. Pharmacol. 55:1873-1880.
42. Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661-671.